Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Anna C. Beck

41 indexed publications match this author name.

ORCID
0000-0003-0592-9540
OpenAlex
https://openalex.org/A5054078305

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Rapid antidepressant effects of psilocybin without increased SV2A binding: baseline binding predicts responsemedRxiv · 2026-11-08Psychedelics Restructure the Global Workspace of ConsciousnessbioRxiv · 2026-10-05Therapists’ Perspectives on the Psychotherapeutic Support in Psilocybin Treatment for Major Depressive Disorder: Insights from a Randomized Controlled TrialResearch Square · 2026-10-05CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-09-01Low-dose lysergic acid diethylamide alters subjective visual perception but not visual contrast surround suppression.Neuroscience of consciousness · 2026-08-20A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major DepressionJAMA Network Open · 2026-05-15The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research.Journal of psychopharmacology (Oxford, England) · 2026-05-01Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30Additional file 1 of Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionFigshare · 2026-04-09Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depressionBMC Medical Education · 2026-04-09Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy VolunteersClinicalTrials.gov · 2026-02-05Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-16Symptom-level antidepressant response to psilocybin: exploratory outcomes comparing psilocybin treatment to niacinNeuroscience Applied · 2026-01-01"Wood-lover paralysis": Describing a toxidrome with symptoms of weakness caused by some lignicolous "wood-loving" Psilocybe mushrooms.Toxicon: official journal of the International Society on Toxinology · 2025-09-01“Wood-lover paralysis”: Describing a toxidrome with symptoms of weakness caused by some lignicolous “wood-loving” Psilocybe mushroomsToxicon · 2025-09-01Motivation and retrospective appraisal of psychedelic study participation: a qualitative study in healthy volunteers.Psychopharmacology · 2025-08-01Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01[Psychedelic psychiatry].Lakartidningen · 2024-04-04The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.Journal of psychopharmacology (Oxford, England) · 2024-01-01Safety pharmacology of acute psilocybin administration in healthy participants.Neuroscience applied · 2024-01-01Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01HOPE: A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer.Journal of pain and symptom management · 2023-09-01Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.Clinical pharmacology and therapeutics · 2023-04-01Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trialJournal of Psychedelic Studies · 2023-01-18Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective.Frontiers in psychiatry · 2023-01-01An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)ClinicalTrials.gov · 2022-10-12Group Format Psilocybin-Assisted Therapy: Commentary on the HOPE trial (HOPE: a pilot study of psilocybin-enhanced group psychotherapy in patients with cancer)Journal of Anesthesiology and Pain Therapy · 2022-10-03Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2022-08-11Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants.Psychopharmacology · 2022-06-01Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2022-05-01Psychoactive Drugs in the Management of Post Traumatic Stress Disorder: A Promising New Horizon.Cureus · 2022-05-01Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects.Clinical pharmacology and therapeutics · 2022-04-01Pharmacokinetics and pharmacokinetic-pharmacodynamic relationship of oral psilocybin administration in healthy subjectsNeuroscience Applied · 2022-01-01Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.Frontiers in psychology · 2022-01-01"Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Cannabis and cannabinoid research · 2018-01-01Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.Scandinavian journal of clinical and laboratory investigation · 2013-08-01Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials.Clinical toxicology (Philadelphia, Pa.) · 2009-07-01A multi-component LC-MS/MS method for detection of ten plant-derived psychoactive substances in urine.Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2009-04-15Presence of phenylethylamine in hallucinogenic Psilocybe mushroom: possible role in adverse reactions.Journal of analytical toxicology · 1998-01-01

Author directory

Robin Carhart-Harris178 publicationsDavid Nutt122 publicationsDavid Erritzøe85 publicationsFranz X. Vollenweider85 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson71 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett61 publicationsGitte M. Knudsen58 publicationsLeor Roseman55 publicationsJames Rucker49 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček45 publicationsPatrick M. Fisher44 publicationsSandeep M. Nayak43 publicationsDea Siggaard Stenbæk42 publicationsJoshua D. Rosenblat42 publicationsKim P. C. Kuypers41 publicationsNatasha L. Mason38 publicationsPeter S. Hendricks38 publicationsAlan K. Davis36 publicationsDavid Bryce Yaden35 publicationsMatthias E. Liechti34 publicationsChristopher Timmermann33 publicationsJohns Hopkins University33 publicationsMuhammad Ishrat Husain33 publicationsBrice Ozenne32 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsRoger S. McIntyre30 publicationsDirk Hoffmeister29 publicationsJohannes G. Ramaekers29 publicationsMichael P. Bogenschutz29 publicationsStephen Ross29 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsBrian Anderson26 publicationsXiaohui Wang26 publicationsCharles D. Nichols25 publicationsDrummond E-Wen McCulloch25 publicationsJavier González-Maeso25 publicationsMartin Korsbak Madsen25 publicationsRichard J. Zeifman25 publicationsAllan H. Young24 publicationsGabrielle Agin-Liebes24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsPaul Liknaitzky24 publicationsFriederike Holze23 publicationsNatalie Gukasyan23 publicationsRAFAEL GUIMARÃES DOS SANTOS23 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsAdam L. Halberstadt21 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsJacob S. Aday21 publicationsJaime E. C. Hallak21 publicationsManoj Doss21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsBenjamin Kelmendi20 publicationsJiřı́ Horáček20 publicationsMichael Kometer20 publicationsAlex Kwan19 publicationsBernard Lerer19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsFelix Müller18 publicationsFilip Tylš18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsChristopher S. Stauffer17 publicationsDavid J. Hellerstein17 publicationsFernando Rosas17 publicationsJason Luoma17 publicationsJeffrey Guss17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsClaire J. Foldi16 publicationsGeyer MA16 publicationsKevin F. Boehnke16 publicationsLea J. Mertens16 publicationsMalievskaia E16 publicationsManish Agrawal16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsAnna M. Becker15 publicationsCharles S. Grob15 publicationsEmmanuelle A. D. Schindler15 publicationsFelix Hasler15 publicationsGerhard Gründer15 publicationsJennifer Jones15 publicationsJoshua S. Siegel15 publicationsKelly JR15 publicationsLindsey Marwood15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsChristopher Pittenger14 publicationsDanica E. Johnson14 publicationsFederico Seragnoli14 publicationsGregor Hasler14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJochen Gartz14 publicationsJosé Carlos Bouso14 publicationsMeg J Spriggs14 publications